World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
49897
World Ranking
6950
National Ranking
75

Petri T. Kovanen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Petri T. Kovanen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 636 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Petri T. Kovanen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Petri T. Kovanen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Petri T. Kovanen is affiliated with the Wihuri Research Institute in Finland and has a research portfolio primarily focused on medicine. Their work spans a broad range of topics within this field, with particular attention to surgery, immunology, cancer research, molecular biology, and endocrinology, diabetes, and metabolism.

The scientist's research interests include several main topics, notably:

  • Lipoproteins and Cardiovascular Health
  • Atherosclerosis and Cardiovascular Diseases
  • Cancer, Lipids, and Metabolism
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • COVID-19 Clinical Research Studies
  • Inflammasome and Immune Disorders
  • Cholesterol and Lipid Metabolism

Their publication record demonstrates a significant presence in scientific journals related to cardiovascular and internal medicine. Frequent publication venues include:

  • Atherosclerosis
  • Frontiers in Cardiovascular Medicine
  • Journal of Internal Medicine
  • Journal of Clinical Lipidology
  • Annals of Medicine

Petri T. Kovanen has collaborated extensively with several researchers. Frequent co-authors are:

  • Alpo Vuorio
  • Frederick J. Raal
  • Katariina Öörni
  • Matti Jauhiainen
  • Miriam Lee-Rueckert

Examples of recent papers associated with topics related to immune cells, cardiovascular health, and metabolism include:

  • "Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts," 2020, Theranostics
  • "Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease," 2020, JCI Insight
  • "Mast cells and complement system: Ancient interactions between components of innate immunity," 2020, Allergy
  • "Cardiac Mast Cells: Underappreciated Immune Cells in Cardiovascular Homeostasis and Disease," 2020, Trends in Immunology
  • "Cyclodextrins: Potential therapeutics against atherosclerosis," 2020, Pharmacology & Therapeutics

These publications indicate involvement in interdisciplinary research connecting immunology, lipid metabolism, and cardiovascular conditions. The overlap of research in innate immunity and metabolic diseases is apparent.

Best Publications

  • Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

    Borge G. Nordestgaard;M. John Chapman;Steve E. Humphries;Henry N. Ginsberg

  • Lipoprotein(a) as a cardiovascular risk factor: current status

    Børge G. Nordestgaard;M. John Chapman;Kausik Ray;Jan Borén

  • Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

    M John Chapman;Henry N Ginsberg;Pierre Amarenco;Felicita Andreotti

  • Regulation of plasma cholesterol by lipoprotein receptors

    Michael S. Brown;Petri T. Kovanen;Joseph L. Goldstein

  • Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    Marina Cuchel;Eric Bruckert;Henry N. Ginsberg;Frederick J. Raal

  • Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation

    Kristiina Rajamäki;Jani Lappalainen;Katariina Öörni;Elina Välimäki

  • Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities

    Magnus Bäck;Arif Yurdagul;Ira Tabas;Katariina Öörni

  • Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability.

    Bernhard Schieffer;Elisabeth Schieffer;Denise Hilfiker-Kleiner;Andres Hilfiker

  • Familial Hypercholesterolaemia in Children and Adolescents: Gaining Decades of Life by Optimizing Detection and Treatment

    Albert Wiegman;Samuel S. Gidding;Gerald F Watts;M John Chapman

  • Infiltrates of Activated Mast Cells at the Site of Coronary Atheromatous Erosion or Rupture in Myocardial Infarction

    Petri T. Kovanen;Maija Kaartinen;Timo Paavonen

  • Homozigot ailevi hiperkolesterolemi: klinisyenlerin tanıyı ve klinik yönetimi geliştirmelerine yönelik yeni anlayışlar ve rehberlik. Avrupa Ateroskleroz Derneği’nin Ailevi Hiperkolesterolemi Üzerine Uzlaşı Paneli yazılı görüşü

    Marina Cuchel;Eric Bruckert;Henry N. Ginsberg;Frederick J. Raal

  • Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture.

    Maija Kaartinen;Antti Penttila;Petri T. Kovanen

  • The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E.

    E. E T Windler;P. T. Kovanen;Y. S. Chao;Michael S Brown

  • The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

    Robert A. Hegele;Henry N. Ginsberg;M. John Chapman;Børge G. Nordestgaard

  • Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL.

    Tiia Hevonoja;Markku O Pentikäinen;Marja T Hyvönen;Petri T Kovanen

  • Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease

    Helena Gylling;Jogchum Plat;Stephen Turley;Henry N. Ginsberg

  • Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells.

    Jussi Taipale;Jouko Lohi;Juhani Saarinen;Petri T. Kovanen

  • Association Between Myocardial Infarction and the Mast Cells in the Adventitia of the Infarct-Related Coronary Artery

    Petri Laine;Maija Kaartinen;Antti Penttilä;Pertti Panula

  • Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.

    W J Schneider;P T Kovanen;M S Brown;J L Goldstein

  • Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase.

    Juhani Saarinen;N. Kalkkinen;H. G. Welgus;P. T. Kovanen

Frequent Co-Authors

Mika Ala-Korpela
Mika Ala-Korpela University of Oulu
Markku Kaste
Markku Kaste University of Helsinki
Marja-Riitta Taskinen
Marja-Riitta Taskinen University of Helsinki
Gerald F. Watts
Gerald F. Watts University of Western Australia
Timo E. Strandberg
Timo E. Strandberg University of Helsinki
Vesa M. Olkkonen
Vesa M. Olkkonen University of Helsinki
Christian Ehnholm
Christian Ehnholm Finnish Institute for Health and Welfare (THL)
Amirhossein Sahebkar
Amirhossein Sahebkar Mashhad University of Medical Sciences
Jan Borén
Jan Borén University of Gothenburg
Pekka Saikku
Pekka Saikku University of Oulu

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean becoming a doctor—many rewarding paths support the healthcare system. For those interested in the business and management side, a health administration degree online can prepare you for leadership roles in hospitals and clinics.

Pursuing further education opens even more doors. Some of the most affordable online mha programs can help set you apart in the competitive world of healthcare administration, offering flexibility for working professionals.

For nurses aiming to advance, the cheapest dnp programs online offer a pathway to the highest clinical roles. These programs allow you to deepen your expertise while managing personal commitments.

If pharmacy is your passion, a pharmacy school online can provide the credentials needed to enter pharmacy practice or research. Online options bring flexibility and affordability to your studies.

With so many online degree options, you can choose a healthcare career that fits your interests, background, and lifestyle, all while balancing cost and convenience.

Best Scientists Citing Petri T. Kovanen

Trending Scientists

Recently Published Articles